5671 - 5680 of 8808 Results
Title
Year
-
OPENTitle: Functional network differences between unilateral and bilateral deep brain stimulation of the subthalamic nucleusJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01064-2Best OA location URL: https://doi.org/10.1038/s41531-025-01064-2Citation Count: 0
-
OPENTitle: Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregationJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 1011End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.bmcl.2018.02.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870887Citation Count: 17
-
OPENTitle: Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset studyJournal Name: Schizophrenia ResearchPublisher: Elsevier BVVol: 214Issue #:Start Page: 3End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.schres.2017.11.038Citation Count: 80
-
OPENTitle: Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00789-wBest OA location URL: https://www.nature.com/articles/s41531-024-00789-w.pdfCitation Count: 11
-
RESTRICTEDTitle: 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigationJournal Name: Basal GangliaPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 9End Page: 13Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.baga.2012.12.002Citation Count: 6
-
OPENTitle: True ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 48Issue #: 8Start Page: 2416End Page: 2425Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-020-05151-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8891344Citation Count: 48
- Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease2016RESTRICTEDTitle: Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 360Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aad8858Citation Count: 68
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://escholarship.org/uc/item/4764f6j3Citation Count: 18
-
RESTRICTEDTitle: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035Citation Count: 1
-
RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 19